Two Sigma Advisers’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
2,093,700
-433,300
| -17% | -$427K | ﹤0.01% | 1107 |
|
|
2025
Q1 | $3.64M | Sell |
2,527,000
-1,089,200
| -30% | -$1.57M | 0.01% | 904 |
|
|
2024
Q4 | $7.96M | Buy |
3,616,200
+16,100
| +0.4% | +$35.4K | 0.02% | 550 |
|
|
2024
Q3 | $5.94M | Sell |
3,600,100
-274,200
| -7% | -$452K | 0.01% | 652 |
|
|
2024
Q2 | $8.6M | Buy |
3,874,300
+304,600
| +9% | +$676K | 0.02% | 580 |
|
|
2024
Q1 | $9.57M | Buy |
3,569,700
+1,423,100
| +66% | +$3.81M | 0.02% | 555 |
|
|
2023
Q4 | $6.42M | Buy |
2,146,600
+610,300
| +40% | +$1.82M | 0.02% | 703 |
|
|
2023
Q3 | $1.51M | Buy |
1,536,300
+851,268
| +124% | +$834K | ﹤0.01% | 1338 |
|
|
2023
Q2 | $952K | Sell |
685,032
-172,168
| -20% | -$239K | ﹤0.01% | 1556 |
|
|
2023
Q1 | $1.36M | Sell |
857,200
-558,800
| -39% | -$888K | ﹤0.01% | 1476 |
|
|
2022
Q4 | $8.82M | Buy |
1,416,000
+331,700
| +31% | +$2.07M | 0.02% | 556 |
|
|
2022
Q3 | $7.27M | Buy |
1,084,300
+1,070,900
| +7,992% | +$7.18M | 0.02% | 592 |
|
|
2022
Q2 | $85K | Buy |
+13,400
| New | +$85K | ﹤0.01% | 2408 |
|
|
2019
Q4 | – | Sell |
-58,400
| Closed | -$2.14M | – | 2382 |
|
|
2019
Q3 | $2.14M | Sell |
58,400
-95,400
| -62% | -$3.5M | 0.01% | 1081 |
|
|
2019
Q2 | $7.16M | Buy |
153,800
+86,300
| +128% | +$4.01M | 0.02% | 703 |
|
|
2019
Q1 | $2.71M | Buy |
67,500
+20,800
| +45% | +$835K | 0.01% | 1090 |
|
|
2018
Q4 | $2.15M | Buy |
+46,700
| New | +$2.15M | 0.01% | 1147 |
|
|
2018
Q2 | – | Sell |
-21,300
| Closed | -$1.54M | – | 2401 |
|
|
2018
Q1 | $1.54M | Sell |
21,300
-2,700
| -11% | -$195K | ﹤0.01% | 1363 |
|
|
2017
Q4 | $1.58M | Buy |
24,000
+9,200
| +62% | +$606K | ﹤0.01% | 1346 |
|
|
2017
Q3 | $742K | Buy |
+14,800
| New | +$742K | ﹤0.01% | 1597 |
|
|
2015
Q3 | – | Sell |
-63,759
| Closed | -$5.21M | – | 1852 |
|
|
2015
Q2 | $5.21M | Buy |
63,759
+41,400
| +185% | +$3.38M | 0.04% | 466 |
|
|
2015
Q1 | $2.07M | Buy |
+22,359
| New | +$2.07M | 0.02% | 752 |
|